scorecardresearch
Wednesday, July 23, 2025
TopicASCI

Topic: ASCI

Digital space hosts lion’s share of misleading healthcare ads, majority on sexual wellness

Healthcare sector accounted for a maximum 19% or 1,569 of 8,229 advertisements scrutinised by ASCI during 2023-24. Nearly 86% of drugs found illegal were on digital platforms.

Ad body ASCI tightens norms, cautions social media influencers over misleading endorsements

The ASCI has also expanded the definition of a 'celebrity' to include notable personalities like doctors, authors, activists, educationists, etc.

Ads for charitable causes shouldn’t make viewer feel ashamed for not contributing, say new ASCI norms

Advertising Standards Council of India also says such ads must not disrespect dignity of those on whose behalf appeal is made & not mislead consumers or cause them unjustified distress.

Drip pricing, false urgency — ASCI releases new guidelines to curb ‘dark patterns’ in online ads

The new guidelines, applicable from 1 September, aim to curb companies misleading consumers about final price, remaining stock, among other 'dark patterns' in online advertising.

Govt, ad body mull industry self-regulation to stop unethical ‘dark patterns’ in advertising

In response to manipulative advertisement techniques violating consumer rights, DoCA and ASCI are encouraging platforms to create user-friendly spaces.

80% don’t notice disclaimers, 62% find them too long — why ad body ASCI updated its guidelines

Use of disclaimers must be kept to minimum, say amended guidelines from Advertising Standards Council of India. This comes in backdrop of new govt rules on social media influencers.

Watchdog flags jump in complaints about misleading ads, says education sector ‘most violative’

Social media influencers are also increasingly violating norms, says ASCI, which received 14% more complaints against ads in April-September 2022 than same period last year.

Disguised ads, hidden costs — regulator ASCI now tackling ‘dark pattern’ ad tactics, says its CEO

No clear central law on what differentiates brand extensions from surrogate ads, other issues like privacy also proving difficult to navigate, self-regulatory body’s CEO says in interview.

On Camera

China’s Brahmaputra dam is also a military asset. It raises alarm for India

China didn't consult India over the Brahmaputra dam. It acted unilaterally over a transboundary river system that feeds millions downstream.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Indian firm sets up titanium, superalloy plants to meet global need. Safran, Dassault, BAE line up

PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.